{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:06:58Z","timestamp":1780038418208,"version":"3.53.1"},"reference-count":298,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371602"],"award-info":[{"award-number":["82371602"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472881"],"award-info":[{"award-number":["82472881"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ30898"],"award-info":[{"award-number":["2023JJ30898"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ5563"],"award-info":[{"award-number":["2024JJ5563"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["2026ZZTS0355"],"award-info":[{"award-number":["2026ZZTS0355"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.critrevonc.2026.105329","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:26:06Z","timestamp":1775575566000},"page":"105329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pediatric thyroid cancer: Distinct pathogenesis, emerging therapeutic strategies and long-term survivorship management"],"prefix":"10.1016","volume":"223","author":[{"given":"Zhi-jun","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105329_bib1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/s41366-020-0523-9","article-title":"Birthweight, childhood overweight, height and growth and adult cancer risks: a review of studies using the Copenhagen School Health Records Register","volume":"44","author":"Aarestrup","year":"2020","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27595","article-title":"Assessment of circulating tumor DNA in pediatric solid tumors: the promise of liquid biopsies","volume":"66","author":"Abbou","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cytogfr.2022.08.003","article-title":"Nefarious NTRK oncogenic fusions in pediatric sarcomas: too many to Trk","volume":"68","author":"Aepala","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.critrevonc.2026.105329_bib4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40618-022-01751-4","article-title":"Sleep quality, stress and thyroid cancer: a case-control study","volume":"45","author":"Afrashteh","year":"2022","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.critrevonc.2026.105329_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Agrawal","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105329_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/ERC-16-0421","article-title":"Comprehensive screening for PD-L1 expression in thyroid cancer","volume":"24","author":"Ahn","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.14639\/0392-100X-N2288","article-title":"TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients","volume":"43","author":"Alaraifi","year":"2023","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"10.1016\/j.critrevonc.2026.105329_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26595","article-title":"Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer","volume":"64","author":"Albano","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76357-y","article-title":"Obesity is positively related and tobacco smoking and alcohol consumption are negatively related to an increased risk of thyroid cancer","volume":"10","author":"An","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105329_bib10","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1158\/1078-0432.CCR-14-0879","article-title":"MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro","volume":"20","author":"Angell","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/00039896.1986.9935763","article-title":"Thyroid cancer incidence in relation to volcanic activity","volume":"41","author":"Arnbj\u00f6rnsson","year":"1986","journal-title":"Arch. Environ. Health"},{"key":"10.1016\/j.critrevonc.2026.105329_bib12","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/archinte.167.13.1428","article-title":"Tobacco smoking and thyroid function: a population-based study","volume":"167","author":"Asvold","year":"2007","journal-title":"Arch. Intern. Me.d"},{"key":"10.1016\/j.critrevonc.2026.105329_bib13","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.3390\/biomedicines11082143","article-title":"Cancer predisposition syndromes and thyroid cancer: keys for a short two-way street","volume":"11","author":"Balinisteanu","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2026.105329_bib14","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamaoto.2021.3077","article-title":"Prevalence and risk factors for multifocality in pediatric thyroid cancer","volume":"147","author":"Banik","year":"2021","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10408398.2020.1714542","article-title":"Nutritional status and follicular-derived thyroid cancer: an update","volume":"61","author":"Barrea","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.critrevonc.2026.105329_bib16","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0252","article-title":"Serum anti-M\u00fcllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer","volume":"13","author":"Barreto","year":"2024","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.critrevonc.2026.105329_bib17","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1210\/jc.2015-4227","article-title":"Tumor-infiltrating T cells and the PD-1 checkpoint pathway in advanced differentiated and anaplastic thyroid cancer","volume":"101","author":"Bastman","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ecl.2020.08.001","article-title":"Pediatric thyroid cancer: genetics, therapeutics and outcome","volume":"49","author":"Bauer","year":"2020","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2026.105329_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ecl.2017.01.014","article-title":"Molecular genetics of thyroid cancer in children and adolescents","volume":"46","author":"Bauer","year":"2017","journal-title":"Endocrinol. Metab. Clin. North Am. Genet. Endocr. Disord."},{"key":"10.1016\/j.critrevonc.2026.105329_bib20","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jpedsurg.2020.02.040","article-title":"Bilateral papillary thyroid cancer in children: risk factors and frequency of postoperative diagnosis","volume":"55","author":"Baumgarten","year":"2020","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib21","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1210\/jc.2004-0431","volume":"89","author":"Belin","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib22","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1158\/2159-8290.CD-21-1136","article-title":"The European MAPPYACTS trial: precision medicine program in pediatric and adolescent patients with recurrent malignancies","volume":"12","author":"Berlanga","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105329_bib23","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1210\/clinem\/dgad322","article-title":"Outcomes of ATA low-risk pediatric thyroid cancer patients not treated with radioactive iodine therapy","volume":"108","author":"Bojarsky","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2026.105329_bib25","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1158\/1078-0432.CCR-20-3558","article-title":"FDA approval summary: selpercatinib for the treatment of lung and thyroid cancers with RET gene mutations or fusions","volume":"27","author":"Bradford","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/jop.12701","article-title":"Pesticides as risk factors for head and neck cancer: a review","volume":"47","author":"Brasil","year":"2018","journal-title":"J. Oral. Pathol. Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib27","doi-asserted-by":"crossref","first-page":"17194","DOI":"10.18632\/oncotarget.7839","article-title":"Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer","volume":"7","author":"Brauner","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105329_bib28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/genes11091039","article-title":"Association between family histories of thyroid cancer and thyroid cancer incidence: a cross-sectional study using the Korean genome and epidemiology study data","volume":"11","author":"Byun","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib29","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1677\/ERC-08-0080","article-title":"Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity","volume":"15","author":"Capezzone","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cancergen.2022.02.009","article-title":"NTRK-fusions in pediatric thyroid tumors: current state and future perspectives","volume":"264\u2013265","author":"Casado-Medrano","year":"2022","journal-title":"Cancer Genet."},{"key":"10.1016\/j.critrevonc.2026.105329_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cancergen.2022.02.009","article-title":"NTRK-fusions in pediatric thyroid tumors: current state and future perspectives","volume":"264\u2013265","author":"Casado-Medrano","year":"2022","journal-title":"Cancer Genet."},{"key":"10.1016\/j.critrevonc.2026.105329_bib32","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf098","article-title":"Redifferentiation effect of larotrectinib for NTRK fusion-positive pediatric thyroid cancer and outcomes after therapy","volume":"9","author":"Castellanos","year":"2025","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.critrevonc.2026.105329_bib33","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1210\/clinem\/dgae576","article-title":"Pediatric papillary thyroid carcinoma: outcomes after surgery without adjuvant radioactive iodine","volume":"110","author":"Castellanos","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib34","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1210\/clinem\/dgae576","article-title":"Pediatric papillary thyroid carcinoma: outcomes after surgery without adjuvant radioactive iodine","volume":"110","author":"Castellanos","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib35","article-title":"A review of complex hormone regulation in thyroid cancer: novel insights beyond the hypothalamus\u2013pituitary\u2013thyroid axis","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib36","doi-asserted-by":"crossref","first-page":"e4242","DOI":"10.1210\/clinem\/dgab210","article-title":"Predictors of bilateral disease in pediatric differentiated thyroid cancer","volume":"106","author":"Cherella","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib37","article-title":"Pediatric thyroid cancer: recent developments","volume":"37","author":"Cherella","year":"2023","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab. Thyroid Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib38","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1515\/jpem-2024-0281","article-title":"Selpercatinib prior to radioactive iodine for pediatric papillary thyroid carcinoma","volume":"37","author":"Chiu","year":"2024","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib39","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1515\/jpem-2024-0281","article-title":"Selpercatinib prior to radioactive iodine for pediatric papillary thyroid carcinoma","volume":"37","author":"Chiu","year":"2024","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib40","first-page":"1187","article-title":"Thyroid cancer risk and smoking status: a meta-analysis","volume":"25","author":"Cho","year":"2014","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.critrevonc.2026.105329_bib41","article-title":"Clinical and genetic features of a large monocentric series of familial non-medullary thyroid cancers","volume":"11","author":"Cirello","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/bdra.20505","article-title":"Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing","volume":"85","author":"Clemens","year":"2009","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/bdra.20505","article-title":"Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing","volume":"85","author":"Clemens","year":"2009","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1158\/2159-8290.CD-20-0571","article-title":"TRK xDFG mutations trigger a sensitivity switch from Type I to II kinase inhibitors","volume":"11","author":"Cocco","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105329_bib45","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib46","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-019-0542-z","article-title":"Resistance to TRK inhibition mediated by convergent MAPK pathway activation","volume":"25","author":"Cocco","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/pch\/pxac123","article-title":"Precision oncology for children: a primer for paediatricians","volume":"28","author":"Cohen-Gogo","year":"2023","journal-title":"Paediatr. Child Health"},{"key":"10.1016\/j.critrevonc.2026.105329_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1956740","article-title":"Thyroid-specific genes expression uncovered age-related differences in pediatric thyroid carcinomas","volume":"2016","author":"Cordioli","year":"2016","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib49","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1210\/jcem.86.10.7950","article-title":"Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches","volume":"86","author":"Corrias","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12940-023-00972-1","article-title":"Socioeconomic disparity in the association between fine particulate matter exposure and papillary thyroid cancer","volume":"22","author":"Crepeau","year":"2023","journal-title":"Environ. Health"},{"key":"10.1016\/j.critrevonc.2026.105329_bib51","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/ERC-21-0414","article-title":"Translating the immune microenvironment of thyroid cancer into clinical practice","volume":"29","author":"Cunha","year":"2022","journal-title":"Endocr. -Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib52","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/01635581.2019.1679194","article-title":"Selenium and thyroid cancer: a systematic review","volume":"72","author":"de Oliveira Maia","year":"2020","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib53","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1089\/thy.2021.0179","article-title":"Bone mineral density in adult survivors of pediatric differentiated thyroid carcinoma: a longitudinal follow-up study","volume":"31","author":"Dekker","year":"2021","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.critrevonc.2026.105329_bib54","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-21-3597","article-title":"Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK fusion-positive solid tumors","volume":"28","author":"Demetri","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib55","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1590\/S0004-27302007000500012","article-title":"Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present","volume":"51","author":"Demidchik","year":"2007","journal-title":"Arq. Bras. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib56","first-page":"374","article-title":"Ethical and social values for paediatric health technology assessment and drug policy","volume":"11","author":"Denburg","year":"2022","journal-title":"Int. J. Health Policy Manag."},{"key":"10.1016\/j.critrevonc.2026.105329_bib57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijporl.2016.08.005","article-title":"Pediatric thyroid cancer: an update from the SEER database 2007\u20132012","volume":"89","author":"Dermody","year":"2016","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib58","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/neuonc\/noac087","article-title":"Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)","volume":"24","author":"Desai","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib59","doi-asserted-by":"crossref","first-page":"57026","DOI":"10.1289\/EHP14849","article-title":"Perinatal exposures to ambient fine particulate matter and outdoor artificial light at night and risk of pediatric papillary thyroid cancer","volume":"133","author":"Deziel","year":"2025","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.critrevonc.2026.105329_bib60","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1089\/thy.2020.0217","article-title":"Birth characteristics and risk of pediatric thyroid cancer: a population-based record-linkage study in California","volume":"31","author":"Deziel","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153098","article-title":"Thyroid cancer and thyroid autoimmune disease: a review of molecular aspects and clinical outcomes","volume":"216","author":"Dias Lopes","year":"2020","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.critrevonc.2026.105329_bib62","article-title":"Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults","volume":"49","author":"Dinauer","year":"1998","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.885597","article-title":"Circulating tumor DNA in pediatric cancer","volume":"9","author":"Doculara","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.critrevonc.2026.105329_bib64","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials","volume":"21","author":"Doebele","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib65","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion\u2013positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib66","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/2159-8290.CD-17-0507","article-title":"A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion\u2013positive solid tumors","volume":"7","author":"Drilon","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105329_bib67","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-18-0484","article-title":"Repotrectinib (Tpx-0005) is a next-generation ros1\/trk\/alk inhibitor that potently inhibits ros1\/trk\/alk solvent-front mutations","volume":"8","author":"Drilon","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105329_bib68","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/2159-8290.CD-18-0484","article-title":"Repotrectinib (TPX-0005) is a next-generation ROS1\/TRK\/ALK inhibitor that potently inhibits ROS1\/TRK\/ALK solvent- front mutations","volume":"8","author":"Drilon","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105329_bib69","first-page":"95","article-title":"Increasing incidence of thyroid carcinoma: risk factors and seeking approaches for primary prevention","volume":"13","author":"Drozd","year":"2020","journal-title":"Korean Thyroid Assoc."},{"key":"10.1016\/j.critrevonc.2026.105329_bib70","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12902-019-0376-1","article-title":"Changes of serum 25(OH) D3 and IGF-1 levels in patients with thyroid nodules","volume":"19","author":"Du","year":"2019","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.critrevonc.2026.105329_bib71","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.aaw4153","article-title":"Ushering in the next generation of precision trials for pediatric cancer","volume":"363","author":"DuBois","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105329_bib72","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/jcem-10-10-1296","article-title":"Cancer of the thyroid in children: a report of 28 cases","volume":"10","author":"Duffy","year":"1950","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib73","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/jc.2018-01478","article-title":"Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers","volume":"104","author":"Dunn","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib74","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1210\/jc.2013-1309","article-title":"Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis","volume":"98","author":"Dvorkin","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib75","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1007\/s00204-025-04111-2","article-title":"In silico & in vitro approaches suggest osteoclastogenesis induction underlying fractures in Entrectinib-treated children","volume":"99","author":"Ehnert","year":"2025","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib76","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.46311","article-title":"Association between genetic risk, adherence to healthy lifestyle behavior, and thyroid cancer risk","volume":"5","author":"Feng","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.critrevonc.2026.105329_bib77","first-page":"1170","article-title":"The ret\/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults","volume":"85","author":"Fenton","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111778","article-title":"Dietary habits and thyroid cancer risk: a hospital-based case-control study in Sicily (South Italy)","volume":"146","author":"Fiore","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105329_bib79","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management GUidelines For Children With Thyroid Nodules And Differentiated Thyroid Cancer","volume":"25","author":"Francis","year":"2015","journal-title":"Thyroid. Off. J. Am. Thyroid. Assoc."},{"key":"10.1016\/j.critrevonc.2026.105329_bib80","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management guidelines for children with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on pediatric thyroid cancer","volume":"25","author":"Francis","year":"2015","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.critrevonc.2026.105329_bib81","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1200\/JCO.21.01861","article-title":"Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers","volume":"40","author":"Franco","year":"2022","journal-title":"JCO"},{"key":"10.1016\/j.critrevonc.2026.105329_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152696","article-title":"Oncogene-specific inhibition in the treatment of advanced pediatric thyroid cancer","volume":"131","author":"Franco","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105329_bib83","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1158\/1078-0432.CCR-23-3417","article-title":"Combination targeted therapy with pembrolizumab and lenvatinib in progressive, radioiodine-refractory differentiated thyroid cancers","volume":"30","author":"French","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib84","first-page":"205","article-title":"Diet and the risk of papillary and follicular thyroid carcinoma: a population-based case-control study in Sweden and Norway","volume":"8","author":"Galanti","year":"1997","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.critrevonc.2026.105329_bib85","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jamaoncol.2022.1655","article-title":"Evaluation of the molecular landscape of pediatric thyroid nodules and use of a multigene genomic classifier in children","volume":"8","author":"Gallant","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib86","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1038\/onc.2009.502","article-title":"DNA breaks at fragile sites generate oncogenic RET\/PTC rearrangements in human thyroid cells","volume":"29","author":"Gandhi","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105329_bib87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4158\/EP.1.1.9","article-title":"Fine-needle aspiration biopsy: use in diagnosis and management of pediatric thyroid diseases","volume":"1","author":"Gharib","year":"1995","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.critrevonc.2026.105329_bib88","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1089\/thy.2022.0407","article-title":"Survivorship, quality of life, and transition to adult care for pediatric and adolescent thyroid cancer survivors","volume":"32","author":"Goldfarb","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib89","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00383-015-3855-0","article-title":"Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients","volume":"32","author":"Golpanian","year":"2016","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.critrevonc.2026.105329_bib90","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/1097-0142(19880315)61:6<1272::AID-CNCR2820610636>3.0.CO;2-8","article-title":"Descriptive epidemiology of thyroid cancer in Hawaii","volume":"61","author":"Goodman","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib91","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_404770","article-title":"Expanding the benefit: dabrafenib\/trametinib as tissue-agnostic therapy for BRAF V600E\u2013positive adult and pediatric solid tumors","author":"Gouda","year":"2023","journal-title":"American Society of Clinical Oncology Educational Book"},{"key":"10.1016\/j.critrevonc.2026.105329_bib92","first-page":"1603","article-title":"Letter to the Editor: Selpercatinib-enhanced radioiodine uptake in RET-rearranged thyroid cancer","volume":"31","author":"Groussin","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib93","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1089\/thy.2021.0524","article-title":"Redifferentiating effect of larotrectinib in NTRK-rearranged advanced radioactive-iodine refractory thyroid cancer","volume":"32","author":"Groussin","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib94","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1089\/thy.2021.0524","article-title":"Redifferentiating effect of larotrectinib in NTRK-rearranged advanced radioactive-iodine refractory thyroid cancer","volume":"32","author":"Groussin","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib95","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/aje\/kwm204","article-title":"Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia","volume":"166","author":"Guignard","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib96","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/ijc.32041","article-title":"Anti-PD-1\/PD-L1 therapy augments lenvatinib\u2019s efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer","volume":"144","author":"Gunda","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib97","article-title":"Single-cell RNA sequencing reveals the heterogeneity in differentiation trajectory and tumor microenvironment leading to more aggressive phenotypes of papillary thyroid cancer in children and young adult patients","volume":"12","author":"Guo","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib98","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1097\/JS9.0000000000001479","article-title":"Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, and large-sample informatics study","volume":"110","author":"Guo","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib99","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011040","article-title":"Immune-related adverse events of neoadjuvant immunotherapy in patients with perioperative cancer: a machine-learning-driven, decade-long informatics investigation","volume":"13","author":"Guo","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib100","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/1097-0142(197005)25:5<1224::AID-CNCR2820250530>3.0.CO;2-R","article-title":"Thyroid cancer in Hawaii","volume":"25","author":"Haber","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib101","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa2309719","article-title":"Phase 3 trial of selpercatinib in advanced RET-mutant medullary thyroid cancer","volume":"389","author":"Hadoux","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib102","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/CEJ.0000000000000481","article-title":"Persistent organic pollutants, pesticides, and the risk of thyroid cancer: systematic review and meta-analysis","volume":"28","author":"Han","year":"2019","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.critrevonc.2026.105329_bib103","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1021\/acs.est.9b02810","article-title":"Associations between Exposure to persistent organic pollutants and thyroid function in a case-control study of East China","volume":"53","author":"Han","year":"2019","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib104","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2967\/jnumed.106.035535","article-title":"Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer","volume":"48","author":"Handkiewicz-Junak","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/01635581.2022.2115082","article-title":"Relationship between serum levels of selenium and thyroid cancer: a systematic review and meta-analysis","volume":"75","author":"Hao","year":"2022","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib106","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.3104","article-title":"Mechanisms of acquired resistance to TRK inhibitors","volume":"40","author":"Harada","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib108","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s00268-009-0364-0","article-title":"Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008","volume":"34","author":"Hay","year":"2010","journal-title":"World J. Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00268-017-4279-x","article-title":"Papillary thyroid carcinoma (PTC) in children and adults: comparison of initial presentation and long-term postoperative outcome in 4432 patients consecutively treated at the Mayo clinic during eight decades (1936\u20132015)","volume":"42","author":"Hay","year":"2018","journal-title":"World J. Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib110","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJMoa1209288","article-title":"Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer","volume":"368","author":"Ho","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib111","first-page":"R173","article-title":"Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers","volume":"29","author":"Hofmann","year":"2022","journal-title":"Endocr. -Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib112","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jss.2009.03.098","article-title":"Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients","volume":"156","author":"Hogan","year":"2009","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib113","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials","volume":"21","author":"Hong","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib114","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s40618-018-0853-9","article-title":"Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis","volume":"41","author":"Hu","year":"2018","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.critrevonc.2026.105329_bib115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/aje\/kwz229","article-title":"Polybrominated diphenyl ethers, polybrominated biphenyls, and risk of papillary thyroid cancer: a nested case-control study","volume":"189","author":"Huang","year":"2020","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib116","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/me.2009-0228","article-title":"SCF, BDNF, and Gas6 are regulators of growth plate chondrocyte proliferation and differentiation","volume":"24","author":"Hutchison","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib117","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1089\/thy.2019.0143","article-title":"Mitogen-activated protein kinase pathway inhibition for redifferentiation of radioiodine refractory differentiated thyroid cancer: an evolving protocol","volume":"29","author":"Iravani","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib118","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamaoto.2021.4455","article-title":"Association between body mass index and thyroid cancer in children with thyroid nodules","volume":"148","author":"Ivanova","year":"2022","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib119","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/thy.2016.0673","article-title":"Identification of three novel fusion oncogenes, SQSTM1\/NTRK3, AFAP1L2\/RET, and PPFIBP2\/RET, in thyroid cancers of young patients in Fukushima","volume":"27","author":"Iyama","year":"2017","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105329_bib120","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1677\/erc.1.00880","article-title":"Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review","volume":"12","author":"Jarzab","year":"2005","journal-title":"Endocr. -Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib121","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/14737159.2017.1316665","article-title":"Ethical considerations surrounding germline next-generation sequencing of children with cancer","volume":"17","author":"Johnson","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2026.105329_bib122","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-2006-924264","article-title":"Serum TSH levels in smokers and non-smokers. The 5th Troms\u00f8 study","volume":"114","author":"Jorde","year":"2006","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.critrevonc.2026.105329_bib123","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/thy.1998.8.197","article-title":"Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma","volume":"8","author":"Kashima","year":"1998","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.critrevonc.2026.105329_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212513","article-title":"Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway","volume":"14","author":"Kato","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2026.105329_bib125","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jamaoto.2020.1340","article-title":"Targeted oncogene therapy before surgery in pediatric patients with advanced invasive thyroid cancer at initial presentation: is it time for a paradigm shift?","volume":"146","author":"Kazahaya","year":"2020","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/359021a0","article-title":"Thyroid cancer after Chernobyl","volume":"359","author":"Kazakov","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105329_bib127","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1089\/thy.2022.0241","article-title":"Autoimmune thyroiditis and risk of malignancy in children with thyroid nodules","volume":"32","author":"Keefe","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29047","article-title":"A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence","volume":"68","author":"Kieran","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29047","article-title":"A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence","volume":"68","author":"Kieran","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib130","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1158\/1078-0432.CCR-17-3572","article-title":"A phase I and pharmacokinetic study of oral dabrafenib in children and adolescent patients with recurrent or refractory BRAF V600 mutation-positive solid tumors","volume":"25","author":"Kieran","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib131","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ijc.25650","article-title":"Dietary nitrate and nitrite and the risk of thyroid cancer in the NIH-AARP Diet and Health Study","volume":"129","author":"Kilfoy","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib132","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/ct.2020;32.375-377","article-title":"The genetic landscape of pediatric thyroid cancer features more fusions and fewer point mutations than seen in adults","volume":"32","author":"Kim","year":"2020","journal-title":"Clin. Thyroidol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib133","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/17512433.2022.2110066","article-title":"Colony stimulating factors for prophylaxis of chemotherapy-induced neutropenia in children","volume":"15","author":"Kim","year":"2022","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib134","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00394-015-1144-2","article-title":"Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area","volume":"56","author":"Kim","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.critrevonc.2026.105329_bib135","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00394-016-1370-2","article-title":"Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area","volume":"57","author":"Kim","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.critrevonc.2026.105329_bib136","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1038\/s41598-020-59245-3","article-title":"Adolescent overweight and obesity and the risk of papillary thyroid cancer in adulthood: a large-scale case-control study","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105329_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30679","article-title":"Use of larotrectinib in a pediatric patient with NTRK-rearranged spindle cell neoplasm and subsequent recurring bone fracture","volume":"70","author":"Kim","year":"2023","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib138","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1007\/s00330-021-07908-8","article-title":"Diagnostic performance of adult-based ATA and ACR-TIRADS ultrasound risk stratification systems in pediatric thyroid nodules: a systematic review and meta-analysis","volume":"31","author":"Kim","year":"2021","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib139","doi-asserted-by":"crossref","unstructured":"Klein Hesselink, M., 2020. Pediatric differentiated thyroid carcinoma: Diagnosis, outcome and late effects of treatment. University of Groningen, [Groningen]. \u3008https:\/\/doi.org\/10.33612\/diss.145073752\u3009.","DOI":"10.33612\/diss.145073752"},{"key":"10.1016\/j.critrevonc.2026.105329_bib140","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1089\/thy.2017.0383","article-title":"Diastolic dysfunction is common in survivors of pediatric differentiated thyroid carcinoma","volume":"27","author":"Klein Hesselink","year":"2017","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.critrevonc.2026.105329_bib141","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/jc.2015-3290","article-title":"Pediatric differentiated thyroid carcinoma in the Netherlands: a nationwide follow-up study","volume":"101","author":"Klein Hesselink","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib142","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/1073110520979389","article-title":"\u201cSomatic\u201d tumor genomic profiling and potentialgermline implications: ethical considerations for children with cancer","volume":"48","author":"Knapp","year":"2020","journal-title":"J. Law Med. Ethics"},{"key":"10.1016\/j.critrevonc.2026.105329_bib143","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.3099","article-title":"Updated analysis of the efficacy and safety of entrectinib in patients (pts) with locally advanced\/metastatic NTRK fusion-positive (NTRK-fp) solid tumors","volume":"40","author":"Krzakowski","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib144","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF02724312","article-title":"Differentiated thyroid cancer","volume":"70","author":"Kumar","year":"2003","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.critrevonc.2026.105329_bib145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/00039896.1981.10667635","article-title":"Volcanoes and carcinoma of the thyroid: a possible association","volume":"36","author":"Kung","year":"1981","journal-title":"Arch. Environ. Health"},{"key":"10.1016\/j.critrevonc.2026.105329_bib146","article-title":"Diet as a possible influencing factor in thyroid cancer incidence: the point of view of the nutritionist","volume":"63","author":"L","year":"2021","journal-title":"Panminerva Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib147","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2015-1158","article-title":"Molecular testing for miRNA, mRNA, and DNA on fine-needle aspiration improves the preoperative diagnosis of thyroid nodules with indeterminate cytology","volume":"100","author":"Labourier","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib148","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1470-2045(18)30119-0","article-title":"Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1\/2 study","volume":"19","author":"Laetsch","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib149","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0959-8049(99)00281-6","article-title":"Thyroid cancer in children: the Royal Marsden Hospital experience","volume":"36","author":"Landau","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174324","article-title":"The landscape of pediatric precision oncology: program design, actionable alterations, and clinical trial development","volume":"13","author":"Langenberg","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105329_bib151","doi-asserted-by":"crossref","first-page":"viii133","DOI":"10.1093\/annonc\/mdy279.397","article-title":"Larotrectinib efficacy and safety in TRK fusion cancer: an expanded clinical dataset showing consistency in an age and tumor agnostic approach","volume":"29","author":"Lassen","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059709","article-title":"Spectrum and risk of neoplasia in Werner syndrome: a systematic review","volume":"8","author":"Lauper","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2026.105329_bib153","first-page":"1124","article-title":"MERAIODE: a phase II redifferentiation trial with trametinib and 131I in metastatic radioactive iodine refractory RAS mutated differentiated thyroid cancer","volume":"33","author":"Leboulleux","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib154","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S2213-8587(25)00064-6","article-title":"Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement","volume":"13","author":"Leboulleux","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib155","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S2213-8587(25)00064-6","article-title":"Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement","volume":"13","author":"Leboulleux","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib156","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1158\/1078-0432.CCR-23-0046","article-title":"A phase II redifferentiation trial with dabrafenib-trametinib and 131I in metastatic radioactive iodine refractory BRAF p.V600E-mutated differentiated thyroid cancer","volume":"29","author":"Leboulleux","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib157","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144847","article-title":"NTRK and RET fusion\u2013directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake","volume":"131","author":"Lee","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105329_bib158","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144847","article-title":"NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake","volume":"131","author":"Lee","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105329_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.802214","article-title":"Predictive values of inflammation-related markers and thyroid function in pediatric thyroid cancer patients","volume":"9","author":"Li","year":"2021","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.critrevonc.2026.105329_bib160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13045-024-01623-9","article-title":"Global cancer statistics for adolescents and young adults: population based study","volume":"17","author":"Li","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib161","article-title":"Advances in PD-1\/PD-L1 pathway inhibitors in the treatment of thyroid cancer: mechanisms and clinical therapeutic perspectives","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib162","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.annonc.2020.09.015","article-title":"Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer","volume":"31","author":"Lin","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib163","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.annonc.2020.05.006","article-title":"Characterization of on-target adverse events caused by TRK inhibitor therapy","volume":"31","author":"Liu","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib164","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12940-025-01172-9","article-title":"Association between long-term exposure to PM2.5 and thyroid nodules in school-aged children and adolescents: a cross-sectional study in Eastern China","volume":"24","author":"Liu","year":"2025","journal-title":"Environ. Health"},{"key":"10.1016\/j.critrevonc.2026.105329_bib165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10238-025-01618-x","article-title":"Role of exercise on the reduction of cancer development: a mechanistic review from the lncRNA point of view","volume":"25","author":"Liu","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib166","article-title":"Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto\u2019s thyroiditis using bioinformatics methods","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105329_bib167","article-title":"Low-dose ionizing radiation-induced RET\/PTC1 rearrangement via the non-homologous end joining pathway to drive thyroid cancer","volume":"2020","author":"Liu","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.critrevonc.2026.105329_bib168","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/jcem.84.2.5443","article-title":"Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma","volume":"84","author":"Loh","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib169","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93106-x","article-title":"Alterations of sleep quality and circadian rhythm genes expression in elderly thyroid nodule patients and risks associated with thyroid malignancy","volume":"11","author":"Lou","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105329_bib170","first-page":"773","article-title":"A pooled analysis of case\u2013control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea","volume":"14","author":"Mack","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.critrevonc.2026.105329_bib171","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1210\/clinem\/dgac731","article-title":"Dynamic risk stratification for predicting long-term outcomes in pediatric differentiated thyroid cancers","volume":"108","author":"Majeed","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib172","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.3390\/cancers12113109","article-title":"Thyroid cancer and circadian clock disruption","volume":"12","author":"Malaguarnera","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib173","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13104-024-07058-2","article-title":"Relationship of modifiable risk factors with the incidence of thyroid cancer: a worldwide study","volume":"18","author":"Maleki","year":"2025","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.critrevonc.2026.105329_bib174","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/neuonc\/noac048","article-title":"TRK inhibition for pediatric and adult central nervous system tumors: Early promise and future questions","volume":"24","author":"Mangum","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib175","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215370","article-title":"Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management","volume":"14","author":"Marotta","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105329_bib176","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/thy.2015.0067","article-title":"Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer","volume":"25","author":"Marti","year":"2015","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.critrevonc.2026.105329_bib177","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31147","article-title":"Barriers to access of precision guided therapies for children with high-risk cancer","volume":"71","author":"Mazariego","year":"2024","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib178","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1200\/JCO.21.02618","article-title":"Pre-existing thyroid autoimmunity and risk of papillary thyroid cancer: a nested case-control study of US active-duty personnel","volume":"40","author":"McLeod","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib179","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1249\/MSS.0000000000001937","article-title":"Physical activity in cancer prevention and survival: a systematic review","volume":"51","author":"McTiernan","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.critrevonc.2026.105329_bib180","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12885-019-5380-3","article-title":"Safety and antitumor activity of the anti\u2013PD-1 antibody pembrolizumab in patients with advanced, PD-L1\u2013positive papillary or follicular thyroid cancer","volume":"19","author":"Mehnert","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib181","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jamcollsurg.2021.03.025","article-title":"Total thyroidectomy vs thyroid lobectomy for localized papillary thyroid cancer in children: a propensity-matched survival analysis","volume":"233","author":"Memeh","year":"2021","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib182","doi-asserted-by":"crossref","unstructured":"Metallo, M., Groza, L., Brunaud, L., Klein, M., Weryha, G., Feigerlova, E., n.d. Long-Term Quality of Life and Pregnancy Outcomes of Differentiated Thyroid Cancer Survivors Treated by Total Thyroidectomy and I131 during Adolescence and Young Adulthood. \u3008https:\/\/doi.org\/10.1155\/2016\/7586482\u3009.","DOI":"10.1155\/2016\/7586482"},{"key":"10.1016\/j.critrevonc.2026.105329_bib183","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.otohns.2007.10.034","article-title":"Papillary thyroid cancer: Pathological parameters as prognostic factors in different classes of age","volume":"138","author":"Miccoli","year":"2008","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib184","article-title":"Pilot study evaluating the addition of cemiplimab in BRAF-mutant anaplastic thyroid cancer after progression on dabrafenib and trametinib","author":"Michel","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib185","first-page":"443","article-title":"Cancer statistics for adolescents and young adults, 2020","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105329_bib186","first-page":"61","article-title":"Radiation exposure and thyroid cancer: a review","author":"Ml","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib187","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.10022","article-title":"Safety and efficacy of selpercatinib in pediatric patients with RET-altered solid tumors: updated results from LIBRETTO-121","volume":"42","author":"Morgenstern","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib188","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.10022","article-title":"Safety and efficacy of selpercatinib in pediatric patients with RET-altered solid tumors: updated results from LIBRETTO-121","volume":"42","author":"Morgenstern","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib189","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/thy.2010.0256","article-title":"Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer","volume":"21","author":"Moses","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib190","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1210\/jc.2012-3070","article-title":"Quality of life in adolescent patients with differentiated thyroid cancer: moving beyond survival","volume":"97","author":"Mostoufi-Moab","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib191","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<97::AID-GCC4>3.0.CO;2-L","article-title":"Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma","volume":"25","author":"Nakata","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib192","unstructured":"National Cancer Institute, Surveillance Research Program; 2024 Apr 17. [updated: 2024 Nov 5; cited 2025 Mar 6]. Available from: \u3008https:\/\/seer.cancer.gov\/statistics-network\/explorer\/\u3009. Data source(s): SEER Incidence Data, November 2023 Submission (1975-2021), SEER 22 registries., n.d."},{"key":"10.1016\/j.critrevonc.2026.105329_bib193","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1530\/EJE-21-0315","article-title":"Long-term male fertility after treatment with radioactive iodine for differentiated thyroid carcinoma","volume":"185","author":"Nies","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib194","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1089\/thy.2019.0560","article-title":"Long-term effects of radioiodine treatment on female fertility in survivors of childhood differentiated thyroid carcinoma","volume":"30","author":"Nies","year":"2020","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.critrevonc.2026.105329_bib195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/EJE-17-0741","article-title":"Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional study","volume":"178","author":"Nies","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib196","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1210\/jc.2016-2246","article-title":"Long-term quality of life in adult survivors of pediatric differentiated thyroid carcinoma","volume":"102","author":"Nies","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib197","doi-asserted-by":"crossref","first-page":"e1683","DOI":"10.1210\/clinem\/dgaa935","article-title":"Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape","volume":"106","author":"Nies","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib198","first-page":"9","article-title":"Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis","volume":"81","author":"Nikiforov","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib199","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/sj.onc.1202120","article-title":"Prevalence of minisatellite and microsatellite instability in radiation-induced post-Chernobyl pediatric thyroid carcinomas","volume":"17","author":"Nikiforov","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105329_bib200","first-page":"1690","article-title":"Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children","volume":"57","author":"Nikiforov","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib201","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1210\/jc.2013-2292","article-title":"Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer","volume":"98","author":"Nikiforova","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib202","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jamaoto.2013.4987","article-title":"Establishing a familial basis for papillary thyroid carcinoma using the Utah Population Database","volume":"139","author":"Oakley","year":"2013","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib203","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10585-024-10276-4","article-title":"Current pharmacologic treatment of brain metastasis in non-small cell lung cancer","volume":"41","author":"Okuno","year":"2024","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.critrevonc.2026.105329_bib204","doi-asserted-by":"crossref","first-page":"e3574","DOI":"10.1210\/clinem\/dgac413","article-title":"Thyroid cancer and pesticide use in a central California agricultural area: a case control study","volume":"107","author":"Omidakhsh","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib205","doi-asserted-by":"crossref","first-page":"E1933","DOI":"10.1210\/jc.2012-1823","article-title":"Quality of life and anxiety in adolescents with differentiated thyroid cancer","volume":"97","author":"Oren","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib206","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41698-024-00711-w","article-title":"The economic costs of precision medicine for clinical translational research among children with high-risk cancer","volume":"8","author":"Owens","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib207","doi-asserted-by":"crossref","DOI":"10.3390\/cimb48010003","article-title":"Neurotrophic control of puberty: from molecular signaling to disorders of pubertal timing","volume":"48","author":"Paparella","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105329_bib208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.semnuclmed.2015.10.006","article-title":"Management of differentiated thyroid cancer in children: focus on the American thyroid association pediatric guidelines","volume":"46","author":"Parisi","year":"2016","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib209","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.21.02838","article-title":"Actionable tumor alterations and treatment protocol enrollment of pediatric and young adult patients with refractory cancers in the national cancer institute\u2013children\u2019s oncology group pediatric MATCH trial","volume":"40","author":"Parsons","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib210","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1200\/JCO.21.01841","article-title":"Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies","volume":"40","author":"Pasqual","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib211","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1200\/JCO.21.01841","article-title":"Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies","volume":"40","author":"Pasqual","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib212","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/EJE-07-0595","article-title":"Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: a population study","volume":"158","author":"Pedersen","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib213","doi-asserted-by":"crossref","first-page":"R577","DOI":"10.1530\/ERC-16-0067","article-title":"Familial non-medullary thyroid cancer: unraveling the genetic maze","volume":"23","author":"Peiling Yang","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib214","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1089\/thy.2019.0802","article-title":"RET, NTRK, ALK, BRAF, and MET fusions in a large cohort of pediatric papillary thyroid carcinomas","volume":"30","author":"Pekova","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib215","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/jnci\/djp354","article-title":"Papillary thyroid cancer incidence in the volcanic area of Sicily","volume":"101","author":"Pellegriti","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2026.105329_bib216","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1089\/thy.2005.15.320","article-title":"BRAF mutations are uncommon in papillary thyroid cancer of young patients","volume":"15","author":"Penko","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib217","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3389\/fendo.2018.00565","article-title":"Hashimoto\u2019s disease and thyroid cancer in children: are they associated?","volume":"9","author":"Penta","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib218","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib219","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-070336","article-title":"Selpercatinib increases radioactive iodine avidity in RET-fusion pediatric thyroid carcinoma","volume":"156","author":"Potter","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.critrevonc.2026.105329_bib220","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-070336","article-title":"Selpercatinib increases radioactive iodine avidity in RET-fusion pediatric thyroid carcinoma","volume":"156","author":"Potter","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.critrevonc.2026.105329_bib221","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/cncr.29887","article-title":"NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States","volume":"122","author":"Prasad","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib222","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5604\/17322693.974647","article-title":"Dietary patterns as risk factors of differentiated thyroid carcinoma","volume":"66","author":"Przybylik-Mazurek","year":"2012","journal-title":"Post. Hig. Med. Dosw (Online)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib223","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jamaoto.2019.0898","article-title":"Pediatric thyroid cancer incidence and mortality trends in the United States, 1973-2013","volume":"145","author":"Qian","year":"2019","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib224","first-page":"1093","article-title":"Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications","volume":"6","author":"Rabes","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib225","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/oncolo\/oyae282","article-title":"Long-term safety of selpercatinib for Rearranged during transfection (RET)-activated advanced solid tumors in LIBRETTO-001: differing patterns of adverse events over time","volume":"29","author":"Raez","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2026.105329_bib226","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.3390\/cancers12113146","article-title":"Genetic landscape of papillary thyroid carcinoma and nuclear architecture: an overview comparing pediatric and adult populations","volume":"12","author":"Rangel-Pozzo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib227","doi-asserted-by":"crossref","unstructured":"Reichenberger, E.R., Bambach, N.E., Spangler, Z., Ricarte-Filho, J.C., Hinkle, K., Isaza, A., Bhatti, T., Bauer, A.J., Franco, A.T., n.d. Single-cell analysis reveals the cellular and transcriptional heterogeneity of the normal pediatric thyroid. Front. Endocrinol. (Lausanne) 17, 1748458. \u3008https:\/\/doi.org\/10.3389\/fendo.2026.1748458\u3009.","DOI":"10.3389\/fendo.2026.1748458"},{"key":"10.1016\/j.critrevonc.2026.105329_bib228","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1007\/s00259-022-05762-4","article-title":"Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidence","volume":"49","author":"Reinecke","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2026.105329_bib229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.19.00060","article-title":"Trial design challenges and approaches for precision oncology in rare tumors: experiences of the children\u2019s oncology group","author":"Renfro","year":"2019","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib230","unstructured":"Research, C. for D.E. and, 2024. FDA grants accelerated approval to repotrectinib for adult and pediatric patients with NTRK gene fusion-positive solid tumors. FDA."},{"key":"10.1016\/j.critrevonc.2026.105329_bib231","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/cancers16020347","article-title":"Expanding our knowledge of DICER1 gene alterations and their role in thyroid diseases","volume":"16","author":"Riascos","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib232","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid\u00ae"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105329_bib233","first-page":"28S","article-title":"The evolving role of (131)I for the treatment of differentiated thyroid carcinoma","volume":"46","author":"Robbins","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib234","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102372","article-title":"Resistance to RET targeted therapy in thyroid cancer: molecular basis and overcoming strategies","volume":"105","author":"Rom\u00e1n-Gil","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2026.105329_bib235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147707","article-title":"Opportunities and challenges of liquid biopsy in thyroid cancer","volume":"22","author":"Romano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105329_bib236","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s41467-022-28848-x","article-title":"The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers","volume":"13","author":"Rosen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105329_bib237","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S2213-8587(21)00049-8","article-title":"A worldwide journey of thyroid cancer incidence centred on tumour histology","volume":"9","author":"Rossi","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib238","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endrev\/bnad022","article-title":"Radiation-related thyroid cancer","volume":"45","author":"Saenko","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.critrevonc.2026.105329_bib239","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.829103","article-title":"Susceptibility genes and chromosomal regions associated with non-syndromic familial non-medullary thyroid carcinoma: some pathogenetic and diagnostic keys","volume":"13","author":"S\u00e1nchez-Ares","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib240","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2967\/jnumed.118.212449","article-title":"Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma","volume":"60","author":"Selvakumar","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib241","doi-asserted-by":"crossref","first-page":"e2580","DOI":"10.1210\/clinem\/dgab192","article-title":"Radioactive iodine treatment for children and young adults with thyroid cancer in South Korea: a population-based study","volume":"106","author":"Seo","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib242","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12011-015-0304-9","article-title":"The association between serum levels of selenium, copper, and magnesium with thyroid cancer: a meta-analysis","volume":"167","author":"Shen","year":"2015","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib243","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/ERC-16-0402","article-title":"A six-genotype genetic prognostic model for papillary thyroid cancer","volume":"24","author":"Shen","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib244","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1067\/msy.2099.101431","article-title":"Coexistent Hashimoto\u2019s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome","volume":"126","author":"Singh","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.critrevonc.2026.105329_bib245","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000351029","article-title":"Indeterminate pediatric thyroid fine needle aspirations: a study of 68 cases","volume":"57","author":"Smith","year":"2013","journal-title":"Acta Cytol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib246","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02303556","article-title":"Iodine 131 thyroid ablation in female children and adolescents: long-term risk of infertility and birth defects","volume":"1","author":"Smith","year":"1994","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib247","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jtho.2020.01.006","article-title":"RET solvent front mutations mediate acquired resistance to selective RET inhibition in RET-driven malignancies","volume":"15","author":"Solomon","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib248","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1252389","article-title":"Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis","volume":"14","author":"Song","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib249","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1210\/jc.2008-0660","article-title":"Clinical and economic outcomes of thyroid and parathyroid surgery in children","volume":"93","author":"Sosa","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib250","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1158\/0008-5472.CAN-21-0761","article-title":"Diverse oncogenic fusions and distinct gene expression patterns define the genomic landscape of pediatric papillary thyroid carcinoma","volume":"81","author":"Stosic","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib251","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/thy.2023.0363","article-title":"Pralsetinib in patients with advanced\/metastatic rearranged during transfection (RET)-altered thyroid cancer: updated efficacy and safety data from the ARROW study","volume":"34","author":"Subbiah","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib252","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S2213-8587(21)00120-0","article-title":"Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1\/2 study","volume":"9","author":"Subbiah","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib253","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.annonc.2021.12.014","article-title":"Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study","volume":"33","author":"Subbiah","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib254","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234566","article-title":"Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis","volume":"15","author":"Subhi","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2026.105329_bib255","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoto.2021.2359","article-title":"Thyroid lobectomy for T1 papillary thyroid carcinoma in pediatric patients","volume":"147","author":"Sudoko","year":"2021","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib256","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoto.2021.2359","article-title":"Thyroid lobectomy for T1 papillary thyroid carcinoma in pediatric patients","volume":"147","author":"Sudoko","year":"2021","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib257","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1089\/thy.2019.0231","article-title":"Risk stratification of pediatric patients with differentiated thyroid cancer: is total thyroidectomy necessary for patients at any risk?","volume":"30","author":"Sugino","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib258","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1515\/jpem-2020-0383","article-title":"Papillary thyroid carcinoma in children with Hashimoto\u2019s thyroiditis \u2013 a review of the literature between 2000 and 2020","volume":"33","author":"Sur","year":"2020","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib259","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2015.00117","article-title":"Familial non-medullary thyroid cancer represents an independent risk factor for increased cancer aggressiveness: a retrospective analysis of 74 families","volume":"6","author":"Tavarelli","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib260","first-page":"ETJ250255","article-title":"Tumor-informed liquid biopsy for monitoring thyroid cancer: a proof-of-concept study","volume":"15","author":"Thomaz","year":"2026","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.critrevonc.2026.105329_bib261","doi-asserted-by":"crossref","first-page":"e3824","DOI":"10.1210\/clinem\/dgac337","article-title":"Selpercatinib treatment of RET-mutated thyroid cancers is associated with gastrointestinal adverse effects","volume":"107","author":"Tsang","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib262","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00268-002-6615-y","article-title":"Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population","volume":"26","author":"Uchino","year":"2002","journal-title":"World J. Surg."},{"key":"10.1016\/j.critrevonc.2026.105329_bib263","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis","volume":"375","author":"Vaccarella","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105329_bib264","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S2213-8587(20)30401-0","article-title":"Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study","volume":"9","author":"Vaccarella","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-8587(20)30426-5","article-title":"Challenges in investigating risk factors for thyroid cancer","volume":"9","author":"Vaccarella","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib266","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1210\/clinem\/dgaf522","article-title":"Long-term outcomes of patients diagnosed with differentiated thyroid cancer in childhood and young adulthood","volume":"111","author":"Valenciaga","year":"2026","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105329_bib267","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.891903","article-title":"Editorial: non-syndromic familial non-medullary thyroid carcinoma: clinical and genetic update","volume":"13","author":"Valerio","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib268","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1089\/thy.2009.1611","article-title":"The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer","volume":"19","author":"Van Nostrand","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib269","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jss.2019.04.036","article-title":"Lobectomy compared to total thyroidectomy for low-risk papillary thyroid cancer: a systematic review","volume":"242","author":"Vargas-Pinto","year":"2019","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2016.10.027","article-title":"Heavy metals in the volcanic environment and thyroid cancer","volume":"457","author":"Vigneri","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib271","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1089\/thy.2020.0702","article-title":"The use of the bethesda system for reporting thyroid cytopathology in pediatric thyroid nodules: a meta-analysis","volume":"31","author":"Vuong","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2026.105329_bib272","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1530\/EJE-21-1259","article-title":"Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma","volume":"186","author":"Waguespack","year":"2022","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105329_bib273","doi-asserted-by":"crossref","DOI":"10.1200\/PO.21.00467","article-title":"Larotrectinib before initial radioactive iodine therapy in pediatric TRK fusion-positive papillary thyroid carcinoma: time to reconsider the treatment paradigm for distantly metastatic disease?","author":"Waguespack","year":"2022","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib274","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1530\/ERC-20-0508","article-title":"Serum TSH is not a risk factor for malignancy of pediatric thyroid nodules","volume":"28","author":"Wang","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib275","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cncy.22104","article-title":"Incidence and malignancy rates of indeterminate pediatric thyroid nodules","volume":"127","author":"Wang","year":"2019","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib276","article-title":"An individualized protein-based prognostic model to stratify pediatric patients with papillary thyroid carcinoma","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105329_bib277","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/EDE.0b013e3181d6201d","article-title":"Nitrate intake and the risk of thyroid cancer and thyroid disease","volume":"21","author":"Ward","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.critrevonc.2026.105329_bib278","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1158\/1078-0432.CCR-22-0437","article-title":"Enhancing radioiodine incorporation into radioiodine-refractory thyroid cancer with MAPK inhibition (ERRITI): a single-center prospective two-arm study","volume":"28","author":"Weber","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib279","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.3390\/cancers13143443","article-title":"Translational utility of liquid biopsies in thyroid cancer management","volume":"13","author":"Wijewardene","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib280","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1002\/lary.31592","article-title":"Age stratification and prognostic factor analysis in pediatric differentiated thyroid cancer","volume":"134","author":"Winder","year":"2024","journal-title":"Laryngoscope"},{"key":"10.1016\/j.critrevonc.2026.105329_bib281","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.23.02503","article-title":"Durability of response with selpercatinib in patients with RET-activated thyroid cancer: long-term safety and efficacy from LIBRETTO-001","volume":"42","author":"Wirth","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib282","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.6024","article-title":"Phase I\/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with anaplastic thyroid cancer","volume":"36","author":"Wirth","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib283","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of Selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.critrevonc.2026.105329_bib284","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/cncr.26398","article-title":"Family history of cancer and risk of sporadic differentiated thyroid carcinoma","volume":"118","author":"Xu","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib285","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.18526","article-title":"Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes","volume":"4","author":"Xu","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.critrevonc.2026.105329_bib286","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14740338.2023.2274426","article-title":"Safety of current treatment options for NTRK fusion-positive cancers","volume":"22","author":"Yang","year":"2023","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.critrevonc.2026.105329_bib287","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14740338.2023.2274426","article-title":"Safety of current treatment options for NTRK fusion-positive cancers","volume":"22","author":"Yang","year":"2023","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.critrevonc.2026.105329_bib288","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaf003","article-title":"Molecular landscape and therapeutic strategies in pediatric differentiated thyroid carcinoma","author":"Yang","year":"2025","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.critrevonc.2026.105329_bib289","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.3390\/cancers13102343","article-title":"Changes in smoking, alcohol consumption, and the risk of thyroid cancer: a population-based korean cohort study","volume":"13","author":"Yeo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib290","unstructured":"Zanella, A.B., Scheffel, R.S., Dora, J.M.S., Fighera, T.M., Spritzer, P.M., Maia, A.L.S., 2017. Evaluation of the effect of suppressive dose of levothyroxine on bone mass in children, adolescents and young adults with differentiated thyroid carcinoma."},{"key":"10.1016\/j.critrevonc.2026.105329_bib291","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202504088","article-title":"Single-cell transcriptomics reveals ITGA2-mediated metabolic reprogramming and immune crosstalk in pediatric thyroid carcinogenesis","author":"Zhan","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib292","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00383-022-05069-3","article-title":"Incidence and prognosis of thyroid cancer in children: based on the SEER database","volume":"38","author":"Zhang","year":"2022","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.critrevonc.2026.105329_bib293","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/cncr.33392","article-title":"Associations between artificial light at night and risk for thyroid cancer: a large US cohort study","volume":"127","author":"Zhang","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105329_bib294","article-title":"The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2026.105329_bib295","doi-asserted-by":"crossref","first-page":"15503","DOI":"10.1021\/acs.jmedchem.1c01539","article-title":"Discovery of next-generation tropomyosin receptor kinase inhibitors for combating multiple resistance associated with protein mutation","volume":"64","author":"Zhuo","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105329_bib296","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S2213-8587(14)70225-6","article-title":"Iodine deficiency and thyroid disorders","volume":"3","author":"Zimmermann","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105329_bib297","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13044-015-0020-8","article-title":"Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies","volume":"8","author":"Zimmermann","year":"2015","journal-title":"Thyroid Res."},{"key":"10.1016\/j.critrevonc.2026.105329_bib298","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13052-019-0693-z","article-title":"Thyrotropin serum levels and coexistence with Hashimoto\u2019s thyroiditis as predictors of malignancy in children with thyroid nodules","volume":"45","author":"Zirilli","year":"2019","journal-title":"Ital. J. Pediatr."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:59:14Z","timestamp":1780037954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826002167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":298,"alternative-id":["S1040842826002167"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105329","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric thyroid cancer: Distinct pathogenesis, emerging therapeutic strategies and long-term survivorship management","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105329"}}